Han S - Search Results

1

Brusatol, an NRF2 inhibitor for future cancer therapeutic.

Cai SJ, Liu Y, Han S, Yang C. Cai SJ, et al. Among authors: han s. Cell Biosci. 2019 Jun 6;9:45. doi: 10.1186/s13578-019-0309-8. eCollection 2019. Cell Biosci. 2019. PMID: 31183074 Free PMC article.

2

mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma.

Liu Y, Lu Y, Li A, Celiku O, Han S, Qian M, Yang C. Liu Y, et al. Among authors: han s. Cancers (Basel). 2020 Mar 26;12(4):787. doi: 10.3390/cancers12040787. Cancers (Basel). 2020. PMID: 32224866 Free PMC article.

3

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets.

Han S, Liu Y, Cai SJ, Qian M, Ding J, Larion M, Gilbert MR, Yang C. Han S, et al. Br J Cancer. 2020 May;122(11):1580-1589. doi: 10.1038/s41416-020-0814-x. Epub 2020 Apr 15. Br J Cancer. 2020. PMID: 32291392 Free PMC article. Review.

4

Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas.

Ruiz-Rodado V, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, Sabedot TS, Munasinghe J, Yang C, Herold-Mende C, Gilbert MR, Cherukuri MK, Noushmehr H, Larion M. Ruiz-Rodado V, et al. Among authors: han s. Neuro Oncol. 2020 Apr 15;22(4):480-492. doi: 10.1093/neuonc/noz207. Neuro Oncol. 2020. PMID: 31665443 Free PMC article.

5

Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma.

Ruiz-Rodado V, Seki T, Dowdy T, Lita A, Zhang M, Han S, Yang C, Cherukuri MK, Gilbert MR, Larion M. Ruiz-Rodado V, et al. Among authors: han s. Cancers (Basel). 2020 Jun 19;12(6):1633. doi: 10.3390/cancers12061633. Cancers (Basel). 2020. PMID: 32575619 Free PMC article.

6

Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nanoadjuvant Enhances the Immunity and Cross-Protection of an NM2e-Based Universal Influenza Vaccine.

Gao Y, Han S, Lu F, Liu Q, Yang J, Wang W, Wang Y, Zhang J, Ju R, Shen X, Zhao Y, Wang H, Tan W, Wang L. Gao Y, et al. Among authors: han s. ACS Nano. 2024 May 9. doi: 10.1021/acsnano.4c00668. Online ahead of print. ACS Nano. 2024. PMID: 38721835

7

Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort.

Lim J, Kim JH, Kim SE, Han SK, Kim TH, Yim HJ, Jung YK, Song DS, Yoon EL, Kim HY, Kang SH, Chang Y, Yoo JJ, Lee SW, Park JG, Park JW, Jeong SW, Suk KT, Kim MY, Kim SG, Kim W, Jang JY, Yang JM, Kim DJ; Korean Acute on‐Chronic Liver Failure (KACLiF) Study Group. Lim J, et al. Among authors: han sk. J Gastroenterol Hepatol. 2024 May 8. doi: 10.1111/jgh.16591. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38720448

8

Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate cancer.

Hong GL, Kim KH, Kim YJ, Lee HJ, Cho SP, Han SY, Yang SW, Lee JS, Kang SK, Lim JS, Jung JY. Hong GL, et al. Among authors: han sy. Biol Res. 2024 May 8;57(1):25. doi: 10.1186/s40659-024-00499-w. Biol Res. 2024. PMID: 38720397

9

Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.

Ji Y, Qin Y, Tan Q, Qiu Y, Han S, Qi X. Ji Y, et al. Among authors: han s. BMC Biotechnol. 2024 May 8;24(1):30. doi: 10.1186/s12896-024-00850-9. BMC Biotechnol. 2024. PMID: 38720310

10

Modification Effects of Homologous Recombination Repair Gene Polymorphisms on the Associations Between Urinary Metals and Breast Cancer Risk.

Han S, Lu M, Zhang Y, Lin Y, Liu Q, Xu L, Ren Z. Han S, et al. Biol Trace Elem Res. 2024 May 8. doi: 10.1007/s12011-024-04215-3. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38720017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,840 results

Search Page